Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Préat V[au]:

Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Ragelle H et al. Expert Opin Drug Deliv. (2017)

PLGA-based nanoparticles: an overview of biomedical applications. Danhier F et al. J Control Release. (2012)

On glioblastoma and the search for a cure: where do we stand? Bianco J et al. Cell Mol Life Sci. (2017)

Search results

Items: 1 to 50 of 251

1.

Novel strategy for oral peptide delivery in incretin-based diabetes treatment.

Xu Y, Van Hul M, Suriano F, Préat V, Cani PD, Beloqui A.

Gut. 2019 Aug 10. pii: gutjnl-2019-319146. doi: 10.1136/gutjnl-2019-319146. [Epub ahead of print]

2.

Combinational drug-loaded lipid nanocapsules for the treatment of cancer.

Tsakiris N, Papavasileiou M, Bozzato E, Lopes A, Vigneron AM, Préat V.

Int J Pharm. 2019 Oct 5;569:118588. doi: 10.1016/j.ijpharm.2019.118588. Epub 2019 Aug 1.

PMID:
31377406
3.

Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.

Zhao M, Bozzato E, Joudiou N, Ghiassinejad S, Danhier F, Gallez B, Préat V.

J Control Release. 2019 Jul 12;309:72-81. doi: 10.1016/j.jconrel.2019.07.015. [Epub ahead of print]

PMID:
31306678
4.

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site.

Lopes A, Feola S, Ligot S, Fusciello M, Vandermeulen G, Préat V, Cerullo V.

J Immunother Cancer. 2019 Jul 10;7(1):174. doi: 10.1186/s40425-019-0644-7.

5.

Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.

Boyd BJ, Bergström CAS, Vinarov Z, Kuentz M, Brouwers J, Augustijns P, Brandl M, Bernkop-Schnürch A, Shrestha N, Préat V, Müllertz A, Bauer-Brandl A, Jannin V.

Eur J Pharm Sci. 2019 Sep 1;137:104967. doi: 10.1016/j.ejps.2019.104967. Epub 2019 Jun 25.

6.

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

Matos AI, Carreira B, Peres C, Moura LIF, Conniot J, Fourniols T, Scomparin A, Martínez-Barriocanal Á, Arango D, Conde JP, Préat V, Satchi-Fainaro R, Florindo HF.

J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. Review.

PMID:
31226355
7.

Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.

Kos S, Lopes A, Preat V, Cemazar M, Lampreht Tratar U, Ucakar B, Vanvarenberg K, Sersa G, Vandermeulen G.

PLoS One. 2019 May 31;14(5):e0217762. doi: 10.1371/journal.pone.0217762. eCollection 2019.

8.

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives.

Lopes A, Vandermeulen G, Préat V.

J Exp Clin Cancer Res. 2019 Apr 5;38(1):146. doi: 10.1186/s13046-019-1154-7. Review.

9.

Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?

O'Driscoll CM, Bernkop-Schnürch A, Friedl JD, Préat V, Jannin V.

Eur J Pharm Sci. 2019 May 15;133:190-204. doi: 10.1016/j.ejps.2019.03.027. Epub 2019 Apr 1. Review.

10.

Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment.

Bastiancich C, Bozzato E, Luyten U, Danhier F, Bastiat G, Préat V.

Int J Pharm. 2019 Mar 25;559:220-227. doi: 10.1016/j.ijpharm.2019.01.042. Epub 2019 Jan 28.

PMID:
30703501
11.

Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma.

Ganipineni LP, Ucakar B, Joudiou N, Riva R, Jérôme C, Gallez B, Danhier F, Préat V.

J Drug Target. 2019 Jun - Jul;27(5-6):614-623. doi: 10.1080/1061186X.2019.1567738. Epub 2019 Jan 24.

PMID:
30633585
12.

The origin of neural stem cells impacts their interactions with targeted-lipid nanocapsules: Potential role of plasma membrane lipid composition and fluidity.

Carradori D, Dos Santos AG, Masquelier J, Paquot A, Saulnier P, Eyer J, Préat V, Muccioli GG, Mingeot-Leclercq MP, des Rieux A.

J Control Release. 2018 Dec 28;292:248-255. doi: 10.1016/j.jconrel.2018.11.005. Epub 2018 Nov 5.

PMID:
30408552
13.

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma.

Lopes A, Vanvarenberg K, Kos Š, Lucas S, Colau D, Van den Eynde B, Préat V, Vandermeulen G.

Sci Rep. 2018 Oct 24;8(1):15732. doi: 10.1038/s41598-018-33933-7.

14.

PLGA: From a classic drug carrier to a novel therapeutic activity contributor.

Chereddy KK, Payen VL, Préat V.

J Control Release. 2018 Nov 10;289:10-13. doi: 10.1016/j.jconrel.2018.09.017. Epub 2018 Sep 20.

PMID:
30244137
15.

Optimized acriflavine-loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer.

Montigaud Y, Ucakar B, Krishnamachary B, Bhujwalla ZM, Feron O, Préat V, Danhier F, Gallez B, Danhier P.

Int J Pharm. 2018 Nov 15;551(1-2):322-328. doi: 10.1016/j.ijpharm.2018.09.034. Epub 2018 Sep 17.

PMID:
30236645
16.

Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.

Bastiancich C, Lemaire L, Bianco J, Franconi F, Danhier F, Préat V, Bastiat G, Lagarce F.

Nanomedicine (Lond). 2018 Aug;13(16):1999-2013. doi: 10.2217/nnm-2018-0057. Epub 2018 Sep 11.

PMID:
30204064
17.

Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma.

Ganipineni LP, Ucakar B, Joudiou N, Bianco J, Danhier P, Zhao M, Bastiancich C, Gallez B, Danhier F, Préat V.

Int J Nanomedicine. 2018 Aug 8;13:4509-4521. doi: 10.2147/IJN.S165184. eCollection 2018.

18.

Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.

Zhao M, Danhier F, Bastiancich C, Joudiou N, Ganipineni LP, Tsakiris N, Gallez B, Rieux AD, Jankovski A, Bianco J, Préat V.

Int J Pharm. 2018 Sep 5;548(1):522-529. doi: 10.1016/j.ijpharm.2018.07.033. Epub 2018 Jul 17.

PMID:
30017818
19.

Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.

Ganipineni LP, Danhier F, Préat V.

J Control Release. 2018 Jul 10;281:42-57. doi: 10.1016/j.jconrel.2018.05.008. Epub 2018 May 17. Review.

PMID:
29753958
20.

PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.

Niu Z, Samaridou E, Jaumain E, Coëne J, Ullio G, Shrestha N, Garcia J, Durán-Lobato M, Tovar S, Santander-Ortega MJ, Lozano MV, Arroyo-Jimenez MM, Ramos-Membrive R, Peñuelas I, Mabondzo A, Préat V, Teixidó M, Giralt E, Alonso MJ.

J Control Release. 2018 Apr 28;276:125-139. doi: 10.1016/j.jconrel.2018.03.004. Epub 2018 Mar 6.

PMID:
29518466
21.

Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing.

Desmet CM, Préat V, Gallez B.

Adv Drug Deliv Rev. 2018 Apr;129:262-284. doi: 10.1016/j.addr.2018.02.001. Epub 2018 Feb 12. Review.

PMID:
29448035
22.

The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.

Shrestha N, Bouttefeux O, Vanvarenberg K, Lundquist P, Cunarro J, Tovar S, Khodus G, Andersson E, Keita ÅV, Gonzalez Dieguez C, Artursson P, Préat V, Beloqui A.

Nanoscale. 2018 Jan 3;10(2):603-613. doi: 10.1039/c7nr07736j.

PMID:
29235598
23.

Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells.

Xu Y, Carradori D, Alhouayek M, Muccioli GG, Cani PD, Préat V, Beloqui A.

Mol Pharm. 2018 Jan 2;15(1):108-115. doi: 10.1021/acs.molpharmaceut.7b00742. Epub 2017 Dec 15.

PMID:
29226685
24.

EPR monitoring of wound oxygenation as a biomarker of response to gene therapy encoding hCAP-18/LL37 peptide.

Desmet CM, Vandermeulen G, Bouzin C, Lam MC, Préat V, Levêque P, Gallez B.

Magn Reson Med. 2018 Jun;79(6):3267-3273. doi: 10.1002/mrm.26956. Epub 2017 Oct 5.

PMID:
28983954
25.

A novel, smaller scaffold for Affitins: Showcase with binders specific for EpCAM.

Kalichuk V, Renodon-Cornière A, Béhar G, Carrión F, Obal G, Maillasson M, Mouratou B, Préat V, Pecorari F.

Biotechnol Bioeng. 2018 Feb;115(2):290-299. doi: 10.1002/bit.26463. Epub 2017 Nov 6.

PMID:
28976545
26.

Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation.

Silva AL, Peres C, Conniot J, Matos AI, Moura L, Carreira B, Sainz V, Scomparin A, Satchi-Fainaro R, Préat V, Florindo HF.

Semin Immunol. 2017 Dec;34:3-24. doi: 10.1016/j.smim.2017.09.003. Epub 2017 Sep 21. Review.

PMID:
28941640
27.

Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma.

Lopes A, Vanvarenberg K, Préat V, Vandermeulen G.

Mol Ther Nucleic Acids. 2017 Sep 15;8:404-415. doi: 10.1016/j.omtn.2017.07.011. Epub 2017 Jul 13.

28.

Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics.

Rodrigues de Azevedo C, von Stosch M, Costa MS, Ramos AM, Cardoso MM, Danhier F, Préat V, Oliveira R.

Int J Pharm. 2017 Oct 30;532(1):229-240. doi: 10.1016/j.ijpharm.2017.08.118. Epub 2017 Sep 1.

PMID:
28867450
29.

Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.

Bastiancich C, Bianco J, Vanvarenberg K, Ucakar B, Joudiou N, Gallez B, Bastiat G, Lagarce F, Préat V, Danhier F.

J Control Release. 2017 Oct 28;264:45-54. doi: 10.1016/j.jconrel.2017.08.019. Epub 2017 Aug 19.

PMID:
28830791
30.

Photosensitizer localization in amphiphilic block copolymers controls photodynamic therapy efficacy.

Ibrahimova V, Denisov SA, Vanvarenberg K, Verwilst P, Préat V, Guigner JM, McClenaghan ND, Lecommandoux S, Fustin CA.

Nanoscale. 2017 Aug 10;9(31):11180-11186. doi: 10.1039/c7nr04403h.

PMID:
28749509
31.

Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potential.

Comune M, Rai A, Chereddy KK, Pinto S, Aday S, Ferreira AF, Zonari A, Blersch J, Cunha R, Rodrigues R, Lerma J, Simões PN, Préat V, Ferreira L.

J Control Release. 2017 Sep 28;262:58-71. doi: 10.1016/j.jconrel.2017.07.007. Epub 2017 Jul 8.

PMID:
28694030
32.

A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation.

Beloqui A, Brayden DJ, Artursson P, Préat V, des Rieux A.

Nat Protoc. 2017 Jul;12(7):1387-1399. doi: 10.1038/nprot.2017.041. Epub 2017 Jun 15.

PMID:
28617450
33.

Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies.

J C Furtado NA, Pirson L, Edelberg H, M Miranda L, Loira-Pastoriza C, Preat V, Larondelle Y, André CM.

Molecules. 2017 Mar 4;22(3). pii: E400. doi: 10.3390/molecules22030400. Review.

34.

On glioblastoma and the search for a cure: where do we stand?

Bianco J, Bastiancich C, Jankovski A, des Rieux A, Préat V, Danhier F.

Cell Mol Life Sci. 2017 Jul;74(13):2451-2466. doi: 10.1007/s00018-017-2483-3. Epub 2017 Feb 17. Review.

PMID:
28210785
35.

The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation.

Carradori D, Eyer J, Saulnier P, Préat V, des Rieux A.

Biomaterials. 2017 Apr;123:77-91. doi: 10.1016/j.biomaterials.2017.01.032. Epub 2017 Jan 27. Review.

PMID:
28161683
36.

Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing.

Kos S, Vanvarenberg K, Dolinsek T, Cemazar M, Jelenc J, Préat V, Sersa G, Vandermeulen G.

Bioelectrochemistry. 2017 Apr;114:33-41. doi: 10.1016/j.bioelechem.2016.12.002. Epub 2016 Dec 10.

PMID:
28006672
37.

A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells.

Beloqui A, Alhouayek M, Carradori D, Vanvarenberg K, Muccioli GG, Cani PD, Préat V.

Mol Pharm. 2016 Dec 5;13(12):4222-4230. Epub 2016 Nov 18.

PMID:
27934480
38.

Poly(lactic acid)-based particulate systems are promising tools for immune modulation.

Peres C, Matos AI, Conniot J, Sainz V, Zupančič E, Silva JM, Graça L, Sá Gaspar R, Préat V, Florindo HF.

Acta Biomater. 2017 Jan 15;48:41-57. doi: 10.1016/j.actbio.2016.11.012. Epub 2016 Nov 4. Review.

PMID:
27826003
39.

The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.

Thwala LN, Beloqui A, Csaba NS, González-Touceda D, Tovar S, Dieguez C, Alonso MJ, Préat V.

J Control Release. 2016 Dec 10;243:109-120. doi: 10.1016/j.jconrel.2016.10.002. Epub 2016 Oct 6.

PMID:
27720993
40.

Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.

Bastiancich C, Danhier P, Préat V, Danhier F.

J Control Release. 2016 Dec 10;243:29-42. doi: 10.1016/j.jconrel.2016.09.034. Epub 2016 Sep 28. Review.

PMID:
27693428
41.

Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures.

Ragelle H, Danhier F, Préat V, Langer R, Anderson DG.

Expert Opin Drug Deliv. 2017 Jul;14(7):851-864. doi: 10.1080/17425247.2016.1244187. Epub 2016 Oct 14. Review.

PMID:
27730820
42.

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin.

Kos S, Blagus T, Cemazar M, Lampreht Tratar U, Stimac M, Prosen L, Dolinsek T, Kamensek U, Kranjc S, Steinstraesser L, Vandermeulen G, Préat V, Sersa G.

Mol Ther Nucleic Acids. 2016 Aug 30;5(8):e356. doi: 10.1038/mtna.2016.65.

43.

NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.

Carradori D, Saulnier P, Préat V, des Rieux A, Eyer J.

J Control Release. 2016 Sep 28;238:253-262. doi: 10.1016/j.jconrel.2016.08.006. Epub 2016 Aug 5.

PMID:
27503706
44.

Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines.

Lambricht L, Vanvarenberg K, De Beuckelaer A, Van Hoecke L, Grooten J, Ucakar B, Lipnik P, Sanders NN, Lienenklaus S, Préat V, Vandermeulen G.

Mol Ther. 2016 Sep;24(9):1686-96. doi: 10.1038/mt.2016.122. Epub 2016 Jun 20.

45.

Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.

Thwala LN, Préat V, Csaba NS.

Expert Opin Drug Deliv. 2017 Jan;14(1):23-36. Epub 2016 Jul 14. Review.

PMID:
27351299
46.

Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.

Jully V, Mathot F, Moniotte N, Préat V, Lemoine D.

J Pharm Sci. 2016 Jun;105(6):1829-1836. doi: 10.1016/j.xphs.2016.03.032.

PMID:
27238481
47.

Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier.

Beloqui A, des Rieux A, Préat V.

Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):242-255. doi: 10.1016/j.addr.2016.04.014. Epub 2016 Apr 23. Review.

PMID:
27117710
48.

A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease.

Beloqui A, Memvanga PB, Coco R, Reimondez-Troitiño S, Alhouayek M, Muccioli GG, Alonso MJ, Csaba N, de la Fuente M, Préat V.

Colloids Surf B Biointerfaces. 2016 Jul 1;143:327-335. doi: 10.1016/j.colsurfb.2016.03.038. Epub 2016 Mar 16.

PMID:
27022873
49.

Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.

Luo T, Magnusson J, Préat V, Frédérick R, Alexander C, Bosquillon C, Vanbever R.

Pharm Res. 2016 Jul;33(7):1671-81. doi: 10.1007/s11095-016-1908-2. Epub 2016 Mar 16.

PMID:
26984129
50.

Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease.

Guada M, Beloqui A, Alhouayek M, Muccioli GG, Dios-Viéitez Mdel C, Préat V, Blanco-Prieto MJ.

Int J Pharm. 2016 Apr 30;503(1-2):196-8. doi: 10.1016/j.ijpharm.2016.03.012. Epub 2016 Mar 10.

PMID:
26972380

Supplemental Content

Support Center